These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 24279385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.
    Larsen TB, Gorst-Rasmussen A, Rasmussen LH, Skjøth F, Rosenzweig M, Lip GY.
    Am J Med; 2014 Jul; 127(7):650-656.e5. PubMed ID: 24530792
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of dabigatran immediately after atrial fibrillation ablation.
    Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
    [Abstract] [Full Text] [Related]

  • 9. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK, Kouides PA.
    Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
    [Abstract] [Full Text] [Related]

  • 10. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M, Yokoyama Y, Sasano T, Hachiya H, Tanaka Y, Yagishita A, Sugiyama K, Nakamura T, Suzuki M, Isobe M, Hirao K.
    J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005
    [Abstract] [Full Text] [Related]

  • 11. A case of dabigatran-associated acute renal failure.
    Shafi ST, Negrete H, Roy P, Julius CJ, Sarac E.
    WMJ; 2013 Aug; 112(4):173-5; quiz 176. PubMed ID: 24734407
    [Abstract] [Full Text] [Related]

  • 12. Hemorrhagic complications associated with dabigatran use.
    Chen BC, Viny AD, Garlich FM, Basciano P, Howland MA, Smith SW, Hoffman RS, Nelson LS.
    Clin Toxicol (Phila); 2012 Nov; 50(9):854-7. PubMed ID: 22970730
    [Abstract] [Full Text] [Related]

  • 13. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J, Pike G, Keighley-Jones L, Nash MJ.
    Am J Med; 2013 Aug; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract] [Full Text] [Related]

  • 14. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 15. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J, Taskiran M.
    Ugeskr Laeger; 2013 Feb 04; 175(6):334-6. PubMed ID: 23402236
    [Abstract] [Full Text] [Related]

  • 16. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.
    Circulation; 2011 May 31; 123(21):2363-72. PubMed ID: 21576658
    [Abstract] [Full Text] [Related]

  • 17. [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
    Spannagl M, Bauersachs R, Debus ES, Gawaz M, Gerlach H, Haas S, Hach-Wunderle V, Lindhoff-Last E, Riess H, Schellong S, Schinzel H, Bode C.
    Hamostaseologie; 2012 May 31; 32(4):294-305. PubMed ID: 23114798
    [Abstract] [Full Text] [Related]

  • 18. New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.
    Barrios V, Escobar C.
    Expert Opin Pharmacother; 2012 Dec 31; 13(18):2649-61. PubMed ID: 23167273
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.
    Singh T, Maw TT, Henry BL, Pastor-Soler NM, Unruh ML, Hallows KR, Nolin TD.
    Clin J Am Soc Nephrol; 2013 Sep 31; 8(9):1533-9. PubMed ID: 23704302
    [Abstract] [Full Text] [Related]

  • 20. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Chevalier J, Giroud M, de Pouvourville G.
    Cerebrovasc Dis; 2013 Sep 31; 35(4):320-6. PubMed ID: 23615428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.